MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 6 55-6, 2004, Pages

  Al Khalili, Lubna ^a   Chibalin, Alexander V ^a   Yu, Mei ^a   Sjödin, Bertil ^a,b   Nylén, Carolina ^a   Zierath, Juleen R ^a   Krook, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Sports University   (Sweden)

Author keywords

Adenosine 5 monophosphate kinase; Cell stress; Insulin; Myocyte enhancer factor 2; Phosphatidylinositol 3 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; HYDROGEN PEROXIDE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENHANCER FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; SYNAPTOPHYSIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MUSCLE CELL; MUSCLE FIBER CULTURE; NONHUMAN; OSMOTIC STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FEMALE; HUMANS; INSULIN; MADS DOMAIN PROTEINS; MALE; MAP KINASE KINASE 1; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; OSMOTIC PRESSURE; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RATS; RATS, WISTAR; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 2442507680     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00444.2003     Document Type: Article

References (45)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995.
2. Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, Holman GD, Ehrenborg E, Ding VDH, Zierath JR, and Krook A. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 60: 991-998, 2003.
3. Al-Khalili L, Krämer D, Wretenberg P, and Krook A. Enhanced insulin-mediated ERK1/2 MAPK and Akt/PKB phosphorylation in cultured human myocytes post differentiation. Acta Physiol Scand 180: 395-403, 2004.
4. Andrews NC and Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.
5. Black BL, Molkentin JD, and Olson EN. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol Cell Biol 18: 69-77, 1998.
6. Black BL and Olson EN. Transcriptional control of muscle development by myocyte enhancer factor 2 (MEF2) proteins. Annu Rev Cell Dev Biol 14: 167-196, 1998.
7. Blough E, Dineen B, and Esser K. Extraction of nuclear proteins from striated muscle tissue. Biotechniques 26: 202-204, 1999.
8. Brand NJ. Myocyte enhancer factor 2 (MEF2). Int J Biochem Cell Biol 29: 1467-1470, 1997.
9. Brand-Saberi B and Christ B. Genetic and epigenetic control of muscle development in vertebrates. Cell Tissue Res 296: 199-212, 1999.
10. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert M, Farese RV Jr, and Farese RV. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-β-D-riboside (AICAR)-stimulated glucose transport. J Biol Chem 277: 23554-23562, 2002.
11. 2, Biochem Biophys Res Commun 287: 92-97, 2001.
12. Cobb MH, Boulton TG, and Robbins DJ. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul 2: 965-978, 1991.
13. Cobb MH and Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
14. Corbit KC, Foster DA, and Rosner MR. Protein kinase Cδ mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol Cell Biol 19: 4209-4218, 1999.
15. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
16. 3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5. J Biol Chem 277: 29643-29653, 2002.
17. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, and Goodyear LJ. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49: 527-531, 2000.
18. Kamakura S, Moriguchi T, and Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 274: 26563-26571, 1999.
19. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, and Lee JD. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 16: 7054-7066, 1997.
20. Kato Y, Zhao M, Morikawa A, Sugiyama T, Chakravortty D, Koide N, Yoshida T, Tapping RI, Yang Y, Yokochi T, and Lee JD. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem 275: 18534-18540, 2000.
21. Kaushal S, Schneider JW, Nadal-Ginard B, and Mahdavi V. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266: 1236-1240, 1994.
22. Krook A, Björnholm M, Jiang XJ, Galuska D, Fahlman R, Myers M, Wallberg-Henriksson H, and Zierath J. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetes 49: 284-292, 2000.
23. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, and Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281: 2042-2045, 1998.
24. Lu J, McKinsey TA, Zhang CL, and Olson EN. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 6: 233-244, 2000.
25. McKinsey TA, Zhang CL, Lu J, and Olson EN. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408: 106-111, 2000.
26. McKinsey TA, Zhang CL, and Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27: 40-47, 2002.
27. Meisse D, Van de Casteele M, Beauloye C, Hainault I, Kefas BA, Rider MH, Foufelle F, and Hue L. Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett 526: 38-42, 2002.
28. Molkentin JD, Black BL, Martin JF, and Olson EN. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136, 1995.
29. Mu J, Brozinick JT Jr, Valladares O, Bucan M and Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094, 2001.
30. Naidu PS, Ludolph DC, To RQ, Hinterberger TJ, and Konieczny SF. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol Cell Biol 15: 2707-2718, 1995.
31. Ryder JW, Chibalin AV, and Zierath JR. Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle. Acta Physiol Scand 171: 249-257, 2001.
32. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, and Zierath JR. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 275: 1457-1462, 2000.
33. Schonwasser DC, Marais RM, Marshall CJ, and Parker PJ. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18: 790-798, 1998.
34. Song XM, Fiedler M, Galuska D, Ryder JW, Fernstrom M, Chibalin AV, Wallberg-Henriksson H, and Zierath JR. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 45: 56-65, 2002.
35. Suzaki Y, Yoshizumi M, Kagami S, Koyama AH, Taketani Y, Houchi H, Tsuchiya K, Takeda E, and Tamaki T. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults. J Biol Chem 277: 9614-9621, 2002.
36. Tamir Y and Bengal E. Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation. J Biol Chem 275: 34424-34432, 2000.
37. Thai MV, Guruswamy S, Cao KT, Pessin JE, and Olson AL. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 273: 14285-14292, 1998.
38. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, and Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
39. Vlahos CJ, Matter WF, Hui KY, and Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248, 1994.
40. Xi X, Han J, and Zhang JZ. Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase. J Biol Chem 276: 41029-41034, 2001.
41. Xu Q and Wu Z. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem 275: 36750-36757, 2000.
42. Yu M, Blomstrand E, Chibalin AV, Krook A, and Zierath JR. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. J Physiol 536: 273-282, 2001.
43. Zetser A, Gredinger E, and Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 274: 5193-5200, 1999.
44. Zheng D, MacLean PS, Pohnert SC, Knight JB, Olson AL, Winder WW, and Dohm GL. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 91: 1073-1083, 2001.
45. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, and Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001.